ES2175752T3 - Lectina de robinia pseudoacacia y sus usos. - Google Patents

Lectina de robinia pseudoacacia y sus usos.

Info

Publication number
ES2175752T3
ES2175752T3 ES98940437T ES98940437T ES2175752T3 ES 2175752 T3 ES2175752 T3 ES 2175752T3 ES 98940437 T ES98940437 T ES 98940437T ES 98940437 T ES98940437 T ES 98940437T ES 2175752 T3 ES2175752 T3 ES 2175752T3
Authority
ES
Spain
Prior art keywords
lectina
robinia pseudoacacia
cells
pseudoacacia
robinia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98940437T
Other languages
English (en)
Inventor
Arpad Janos Rowett Pusztai
Zsuszanna Magdolna Row Bardocz
Richard Michael John Al Palmer
Neil William Alizyme Ther Fish
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alizyme Therapeutics Ltd
Original Assignee
Alizyme Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alizyme Therapeutics Ltd filed Critical Alizyme Therapeutics Ltd
Application granted granted Critical
Publication of ES2175752T3 publication Critical patent/ES2175752T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Uso de lectina de Robinia pseudoacacia en la fabricación de un medicamento para el control de la proliferación de células mucosas, para la reducción y/o el tratamiento del daño provocado por un agente que daña las células, o una combinación de los mismos.
ES98940437T 1997-08-29 1998-08-28 Lectina de robinia pseudoacacia y sus usos. Expired - Lifetime ES2175752T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9718413.9A GB9718413D0 (en) 1997-08-29 1997-08-29 Compositions

Publications (1)

Publication Number Publication Date
ES2175752T3 true ES2175752T3 (es) 2002-11-16

Family

ID=10818276

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98940437T Expired - Lifetime ES2175752T3 (es) 1997-08-29 1998-08-28 Lectina de robinia pseudoacacia y sus usos.

Country Status (13)

Country Link
EP (1) EP1009418B1 (es)
JP (1) JP2001514230A (es)
CN (1) CN1170587C (es)
AT (1) ATE214935T1 (es)
AU (1) AU740353B2 (es)
CA (1) CA2301848A1 (es)
DE (1) DE69804466T2 (es)
ES (1) ES2175752T3 (es)
GB (1) GB9718413D0 (es)
HU (1) HU225762B1 (es)
NZ (1) NZ502971A (es)
RU (1) RU2214259C2 (es)
WO (1) WO1999011278A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
US6310195B1 (en) 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor
US6991794B1 (en) 1997-06-24 2006-01-31 Imclone Systems Incorporated Progenitor cell preservation factors and methods for and products of their use
ATE501724T1 (de) * 2009-02-10 2011-04-15 Helvista Ag Lektinzusammensetzung zur prophylaxe und/oder behandlung von unerwünschten arzneimittelnebenwirkungen
DE102010033458B4 (de) 2010-08-05 2016-03-10 Helvista Ag Emulgierte Lektinzusammensetzungen und ihre Verwendung
KR101836679B1 (ko) 2015-08-19 2018-04-20 중앙대학교 산학협력단 아까시나무 잎 추출물을 유효성분으로 함유하는 ＩＬ－１β 관련 질환 예방 또는 치료용 약학조성물
RU2746424C1 (ru) * 2019-11-05 2021-04-13 Федеральное государственное бюджетное образовательное учреждение высшего образования «Астраханский государственный медицинский университет» Министерства здравоохранения Российской Федерации Способ выделения лектина бобов солодки гладкой
CA3227834A1 (en) * 2021-08-30 2023-03-09 Dhananjay Sathe Protein compositions for the treatment of inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61280432A (ja) * 1985-06-05 1986-12-11 Asahi Chem Ind Co Ltd 抗腫瘍免疫細胞誘導方法
RU1799599C (ru) * 1990-11-16 1993-03-07 Львовский государственный медицинский институт Способ получени лектина

Also Published As

Publication number Publication date
CN1170587C (zh) 2004-10-13
DE69804466D1 (de) 2002-05-02
RU2214259C2 (ru) 2003-10-20
DE69804466T2 (de) 2002-11-14
CN1273533A (zh) 2000-11-15
WO1999011278A1 (en) 1999-03-11
AU740353B2 (en) 2001-11-01
HUP0003537A3 (en) 2002-01-28
ATE214935T1 (de) 2002-04-15
GB9718413D0 (en) 1997-11-05
AU8876398A (en) 1999-03-22
HU225762B1 (en) 2007-08-28
EP1009418A1 (en) 2000-06-21
HUP0003537A2 (hu) 2001-02-28
EP1009418B1 (en) 2002-03-27
NZ502971A (en) 2003-02-28
CA2301848A1 (en) 1999-03-11
JP2001514230A (ja) 2001-09-11

Similar Documents

Publication Publication Date Title
CO5150154A1 (es) Composicion de sustrato y metodo para usarlo para el secuestro de irritantes de la piel
AR031301A1 (es) Composicion para la decoloracion o la deformacion permanente de fibras queratinicas que comprende un poliuretano asociativo cationico
SV2002000520A (es) Derivados de pirazol ref. pcs10927aajr/bb
ES2185816T3 (es) Formas de dosificacion farmaceutica para la via oral, que comprenden un agente inhibidor de la bomba de protones y un agente procinetico.
ES2110375T1 (es) Agente antiinflamatorio para uso externo.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
AR028678A1 (es) Nuevos compuestos de la familia de las n-acilamino-amidas, composiciones que los comprenden, y utilizaciones
AR046970A1 (es) Esteres de fosfato de florfenicol
ES2040137T3 (es) Agente para la tincion del pelo y su empleo.
ES2175752T3 (es) Lectina de robinia pseudoacacia y sus usos.
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
AR032872A1 (es) Composicion para aclarar la piel y el metodo de aplicacion
ES2183341T3 (es) Utilizacion cosmetica o dermatoloogica de esteroides 7-hidroxilados.
ES2103493T3 (es) Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
AR020781A1 (es) Uso de composicion oftalmica
ES2193065T3 (es) Nueva utilizacion del saredutant.
AR015956A1 (es) Composiciones de citoquinas oromucosales y usos de las mismas
ES2052484T1 (es) N-(5-tioxo-l-prolil)-l-cisteina, sus derivados, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
MX9304117A (es) Agente cosmetico para el tratamiento de la piel, contra el envejecimiento provocado por los rayos ultravioleta y procedimiento para su obtencion.
ES2111752T3 (es) Agente para el tratamiento del cabello.
ES2172558T3 (es) Lubricante compatible con radiaciones para dispositivos medicos.
AR045392A1 (es) Composiciones para el tratamiento del cabello
MX9405371A (es) Derivado de naftilo.
AR008778A1 (es) Composiciones para el tenido por oxidacion de fibras queratinicas, procedimiento de tintura y dispositivo de tintura de varios compartimientos
ES2055680T3 (es) Fijador y procedimiento para el moldeado permanente del cabello.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 1009418

Country of ref document: ES